| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.21▼ | 3.21▼ | 3.21▲ | 3.17▲ | 3.30▼ |
| MA10 | 3.22▼ | 3.21▼ | 3.20▲ | 3.18▲ | 3.35▼ |
| MA20 | 3.21▼ | 3.20▲ | 3.19▲ | 3.23▼ | 3.30▼ |
| MA50 | 3.20▲ | 3.21▲ | 3.20▲ | 3.33▼ | 4.18▼ |
| MA100 | 3.20▲ | 3.22▼ | 3.27▼ | 3.28▼ | N/A |
| MA200 | 3.21▼ | 3.26▼ | 3.24▼ | 3.38▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.002▲ | 0.004▲ | -0.001▼ | 0.101▲ |
| RSI | 50.531▲ | 51.404▲ | 51.895▲ | 48.854▼ | 44.017▼ |
| STOCH | 21.746 | 44.792 | 43.056 | 26.114 | 30.183 |
| WILL %R | -80.000▼ | -60.000 | -60.000 | -73.603 | -75.290▼ |
| CCI | -20.833 | 62.654 | 83.333 | -27.293 | -67.415 |
|
Monday, November 18, 2024 09:37 AM
Boston Scientific (NYSE:BSX) stock climbed 5% Monday after the medical device maker announced a study has shown its Watchman FLX device was superior to oral anti-coagulant medication in reducing ...
|
|
Monday, November 18, 2024 04:15 AM
On Saturday, Boston Scientific Corporation (NYSE:BSX) unveiled three-year primary endpoint results from the OPTION global clinical trial of the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device ...
|
|
Tuesday, October 08, 2024 09:05 AM
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/12/25 | 3.25 | 3.285 | 3.20 | 3.21 | 55,717 |
| 23/12/25 | 3.15 | 3.25 | 3.15 | 3.16 | 144,662 |
| 22/12/25 | 3.24 | 3.27 | 3.13 | 3.13 | 128,105 |
| 19/12/25 | 3.22 | 3.305 | 3.135 | 3.16 | 185,600 |
| 18/12/25 | 3.26 | 3.49 | 3.18 | 3.21 | 141,040 |
| 17/12/25 | 3.20 | 3.25 | 3.16 | 3.21 | 178,648 |
| 16/12/25 | 3.09 | 3.245 | 3.053 | 3.19 | 113,000 |
| 15/12/25 | 3.28 | 3.28 | 3.0522 | 3.09 | 62,379 |
| 12/12/25 | 3.31 | 3.44 | 3.21 | 3.23 | 133,973 |
| 11/12/25 | 3.23 | 3.33 | 3.21 | 3.25 | 187,500 |
|
|
||||
|
|
||||
|
|